Intracellular TCR-signaling pathway: Novel markers for lymphoma diagnosis and potential therapeutic targets

Claudio Agostinelli, Hasan Rizvi, Jennifer Paterson, Vishvesh Shende, Ayse U. Akarca, Elena Agostini, Fabio Fuligni, Simona Righi, Sebastiano Spagnolo, Pier Paolo Piccaluga, Edward A. Clark, Stefano A. Pileri, Teresa Marafioti

Research output: Contribution to journalArticle

Abstract

Despite the immunologic functions of T-cell receptor signaling molecules being extensively investigated, their potential as immunohistochemical markers has been poorly explored. With this background, we evaluated the expression of 5 intracellular proteins-GADS, DOK2, SKAP55, ITK, and PKCα- involved in T-cell receptor signaling in normal and neoplastic hematologic tissue samples, using antibodies raised against fixation-resistant epitopes of the 5 molecules. All 5 antibodies were associated with normal T-cell differentiation. GADS, DOK2, SKAP55, and ITK turned out to be T-cell lineage-specific markers in the setting of lymphoid and myeloid precursor neoplasms but showed differential expression in peripheral T-cell lymphoma (PTCL) subtypes, being detected in PTCL/not otherwise specified (NOS) and angioimmunoblastic T-cell lymphoma but negative in anaplastic large cell lymphoma (ALCL). Peripheral B-cell lymphomas were consistently negative for ITK, with occasional cases showing expression of DOK2 and SKAP55, and a proportion (47%) of hairy cell leukemias were GADS+. Notably, PKCα highlighted a defective antigen in both PTCL/NOS (6%) and angioimmunoblastic T-cell lymphoma (10%), mostly negative in ALCL, and was aberrantly expressed in classical Hodgkin lymphoma (65%), Burkitt lymphoma (48%), and plasma cell myeloma (48%). In conclusion, all five molecules evaluated play a role in T-cell differentiation in normal and neoplastic tissues. They can be applied confidently to routine sections contributing primarily to assignment of Tlineage differentiation in the setting of hematopoietic precursor neoplasms (GADS/DOK2/SKAP55/ITK) and for the differential diagnosis between ALCL and PTCL/NOS (GADS/DOK2/SKAP55/ITK) or classical Hodgkin lymphoma (PKCα). Finally, association with specific tumor subtypes may have therapeutic potential.

Original languageEnglish
Pages (from-to)1349-1359
Number of pages11
JournalAmerican Journal of Surgical Pathology
Volume38
Issue number10
Publication statusPublished - 2014

Fingerprint

Peripheral T-Cell Lymphoma
Anaplastic Large-Cell Lymphoma
Lymphoma
T-Cell Lymphoma
T-Cell Antigen Receptor
T-Lymphocytes
Hodgkin Disease
Cell Differentiation
Hairy Cell Leukemia
Burkitt Lymphoma
Antibodies
B-Cell Lymphoma
Cell Lineage
Hematologic Neoplasms
Therapeutics
Multiple Myeloma
Epitopes
Neoplasms
Differential Diagnosis
Antigens

Keywords

  • Immunohistochemistry
  • Lymphomas
  • T-cell receptor signaling
  • Tissue microarray

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine
  • Surgery
  • Medicine(all)

Cite this

Agostinelli, C., Rizvi, H., Paterson, J., Shende, V., Akarca, A. U., Agostini, E., ... Marafioti, T. (2014). Intracellular TCR-signaling pathway: Novel markers for lymphoma diagnosis and potential therapeutic targets. American Journal of Surgical Pathology, 38(10), 1349-1359.

Intracellular TCR-signaling pathway : Novel markers for lymphoma diagnosis and potential therapeutic targets. / Agostinelli, Claudio; Rizvi, Hasan; Paterson, Jennifer; Shende, Vishvesh; Akarca, Ayse U.; Agostini, Elena; Fuligni, Fabio; Righi, Simona; Spagnolo, Sebastiano; Piccaluga, Pier Paolo; Clark, Edward A.; Pileri, Stefano A.; Marafioti, Teresa.

In: American Journal of Surgical Pathology, Vol. 38, No. 10, 2014, p. 1349-1359.

Research output: Contribution to journalArticle

Agostinelli, C, Rizvi, H, Paterson, J, Shende, V, Akarca, AU, Agostini, E, Fuligni, F, Righi, S, Spagnolo, S, Piccaluga, PP, Clark, EA, Pileri, SA & Marafioti, T 2014, 'Intracellular TCR-signaling pathway: Novel markers for lymphoma diagnosis and potential therapeutic targets', American Journal of Surgical Pathology, vol. 38, no. 10, pp. 1349-1359.
Agostinelli C, Rizvi H, Paterson J, Shende V, Akarca AU, Agostini E et al. Intracellular TCR-signaling pathway: Novel markers for lymphoma diagnosis and potential therapeutic targets. American Journal of Surgical Pathology. 2014;38(10):1349-1359.
Agostinelli, Claudio ; Rizvi, Hasan ; Paterson, Jennifer ; Shende, Vishvesh ; Akarca, Ayse U. ; Agostini, Elena ; Fuligni, Fabio ; Righi, Simona ; Spagnolo, Sebastiano ; Piccaluga, Pier Paolo ; Clark, Edward A. ; Pileri, Stefano A. ; Marafioti, Teresa. / Intracellular TCR-signaling pathway : Novel markers for lymphoma diagnosis and potential therapeutic targets. In: American Journal of Surgical Pathology. 2014 ; Vol. 38, No. 10. pp. 1349-1359.
@article{aca71469b130429bacbc28b51c99f7c0,
title = "Intracellular TCR-signaling pathway: Novel markers for lymphoma diagnosis and potential therapeutic targets",
abstract = "Despite the immunologic functions of T-cell receptor signaling molecules being extensively investigated, their potential as immunohistochemical markers has been poorly explored. With this background, we evaluated the expression of 5 intracellular proteins-GADS, DOK2, SKAP55, ITK, and PKCα- involved in T-cell receptor signaling in normal and neoplastic hematologic tissue samples, using antibodies raised against fixation-resistant epitopes of the 5 molecules. All 5 antibodies were associated with normal T-cell differentiation. GADS, DOK2, SKAP55, and ITK turned out to be T-cell lineage-specific markers in the setting of lymphoid and myeloid precursor neoplasms but showed differential expression in peripheral T-cell lymphoma (PTCL) subtypes, being detected in PTCL/not otherwise specified (NOS) and angioimmunoblastic T-cell lymphoma but negative in anaplastic large cell lymphoma (ALCL). Peripheral B-cell lymphomas were consistently negative for ITK, with occasional cases showing expression of DOK2 and SKAP55, and a proportion (47{\%}) of hairy cell leukemias were GADS+. Notably, PKCα highlighted a defective antigen in both PTCL/NOS (6{\%}) and angioimmunoblastic T-cell lymphoma (10{\%}), mostly negative in ALCL, and was aberrantly expressed in classical Hodgkin lymphoma (65{\%}), Burkitt lymphoma (48{\%}), and plasma cell myeloma (48{\%}). In conclusion, all five molecules evaluated play a role in T-cell differentiation in normal and neoplastic tissues. They can be applied confidently to routine sections contributing primarily to assignment of Tlineage differentiation in the setting of hematopoietic precursor neoplasms (GADS/DOK2/SKAP55/ITK) and for the differential diagnosis between ALCL and PTCL/NOS (GADS/DOK2/SKAP55/ITK) or classical Hodgkin lymphoma (PKCα). Finally, association with specific tumor subtypes may have therapeutic potential.",
keywords = "Immunohistochemistry, Lymphomas, T-cell receptor signaling, Tissue microarray",
author = "Claudio Agostinelli and Hasan Rizvi and Jennifer Paterson and Vishvesh Shende and Akarca, {Ayse U.} and Elena Agostini and Fabio Fuligni and Simona Righi and Sebastiano Spagnolo and Piccaluga, {Pier Paolo} and Clark, {Edward A.} and Pileri, {Stefano A.} and Teresa Marafioti",
year = "2014",
language = "English",
volume = "38",
pages = "1349--1359",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Intracellular TCR-signaling pathway

T2 - Novel markers for lymphoma diagnosis and potential therapeutic targets

AU - Agostinelli, Claudio

AU - Rizvi, Hasan

AU - Paterson, Jennifer

AU - Shende, Vishvesh

AU - Akarca, Ayse U.

AU - Agostini, Elena

AU - Fuligni, Fabio

AU - Righi, Simona

AU - Spagnolo, Sebastiano

AU - Piccaluga, Pier Paolo

AU - Clark, Edward A.

AU - Pileri, Stefano A.

AU - Marafioti, Teresa

PY - 2014

Y1 - 2014

N2 - Despite the immunologic functions of T-cell receptor signaling molecules being extensively investigated, their potential as immunohistochemical markers has been poorly explored. With this background, we evaluated the expression of 5 intracellular proteins-GADS, DOK2, SKAP55, ITK, and PKCα- involved in T-cell receptor signaling in normal and neoplastic hematologic tissue samples, using antibodies raised against fixation-resistant epitopes of the 5 molecules. All 5 antibodies were associated with normal T-cell differentiation. GADS, DOK2, SKAP55, and ITK turned out to be T-cell lineage-specific markers in the setting of lymphoid and myeloid precursor neoplasms but showed differential expression in peripheral T-cell lymphoma (PTCL) subtypes, being detected in PTCL/not otherwise specified (NOS) and angioimmunoblastic T-cell lymphoma but negative in anaplastic large cell lymphoma (ALCL). Peripheral B-cell lymphomas were consistently negative for ITK, with occasional cases showing expression of DOK2 and SKAP55, and a proportion (47%) of hairy cell leukemias were GADS+. Notably, PKCα highlighted a defective antigen in both PTCL/NOS (6%) and angioimmunoblastic T-cell lymphoma (10%), mostly negative in ALCL, and was aberrantly expressed in classical Hodgkin lymphoma (65%), Burkitt lymphoma (48%), and plasma cell myeloma (48%). In conclusion, all five molecules evaluated play a role in T-cell differentiation in normal and neoplastic tissues. They can be applied confidently to routine sections contributing primarily to assignment of Tlineage differentiation in the setting of hematopoietic precursor neoplasms (GADS/DOK2/SKAP55/ITK) and for the differential diagnosis between ALCL and PTCL/NOS (GADS/DOK2/SKAP55/ITK) or classical Hodgkin lymphoma (PKCα). Finally, association with specific tumor subtypes may have therapeutic potential.

AB - Despite the immunologic functions of T-cell receptor signaling molecules being extensively investigated, their potential as immunohistochemical markers has been poorly explored. With this background, we evaluated the expression of 5 intracellular proteins-GADS, DOK2, SKAP55, ITK, and PKCα- involved in T-cell receptor signaling in normal and neoplastic hematologic tissue samples, using antibodies raised against fixation-resistant epitopes of the 5 molecules. All 5 antibodies were associated with normal T-cell differentiation. GADS, DOK2, SKAP55, and ITK turned out to be T-cell lineage-specific markers in the setting of lymphoid and myeloid precursor neoplasms but showed differential expression in peripheral T-cell lymphoma (PTCL) subtypes, being detected in PTCL/not otherwise specified (NOS) and angioimmunoblastic T-cell lymphoma but negative in anaplastic large cell lymphoma (ALCL). Peripheral B-cell lymphomas were consistently negative for ITK, with occasional cases showing expression of DOK2 and SKAP55, and a proportion (47%) of hairy cell leukemias were GADS+. Notably, PKCα highlighted a defective antigen in both PTCL/NOS (6%) and angioimmunoblastic T-cell lymphoma (10%), mostly negative in ALCL, and was aberrantly expressed in classical Hodgkin lymphoma (65%), Burkitt lymphoma (48%), and plasma cell myeloma (48%). In conclusion, all five molecules evaluated play a role in T-cell differentiation in normal and neoplastic tissues. They can be applied confidently to routine sections contributing primarily to assignment of Tlineage differentiation in the setting of hematopoietic precursor neoplasms (GADS/DOK2/SKAP55/ITK) and for the differential diagnosis between ALCL and PTCL/NOS (GADS/DOK2/SKAP55/ITK) or classical Hodgkin lymphoma (PKCα). Finally, association with specific tumor subtypes may have therapeutic potential.

KW - Immunohistochemistry

KW - Lymphomas

KW - T-cell receptor signaling

KW - Tissue microarray

UR - http://www.scopus.com/inward/record.url?scp=84908530388&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908530388&partnerID=8YFLogxK

M3 - Article

C2 - 25118816

AN - SCOPUS:84908530388

VL - 38

SP - 1349

EP - 1359

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

IS - 10

ER -